RxDoctor Payments Data

Jean Huynh, PA

Medical · Riverside, CANPI 1821493230

Payments from drug & device makers

$4,191in general payments, 2019–2025

Across 182 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$602
  • UCB, Inc.$586
  • Boehringer Ingelheim$556
  • Mallinckrodt Hospital Products Inc.$537
  • Amgen$510
  • AbbVie$420
  • plus $980 from 9 others

What the payments were for

  • Food & beverage$4,191100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,191 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.

See all medical providers in California

Medicare billing

Part B allowed, 2024
$285,810
Medicare patients
205
Services billed
15,972

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib11$68,156
Leflunomide44$3,276
Hydroxychloroquine Sulfate72$2,976
Azithromycin51$1,842
MethotrexateMethotrexate Sodium32$1,239
Minocycline Hcl49$1,043
Diclofenac Sodium14$963
Gabapentin74$830
Prednisone95$660
Doxycycline Hyclate18$442
Omeprazole15$357
Methocarbamol14$304
Ibuprofen41$298
Levothyroxine Sodium19$253
Alprazolam24$211

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$420$68,15611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 medical providers in California.

Other medical in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →